BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 37066059)

  • 1. Analysis of Transfusion-Transmitted Bacterial Infections according to German Hemovigilance Data (2011-2020).
    Orru' S; Oberle D; Heiden M; Müller S; Krut O; Funk MB
    Transfus Med Hemother; 2023 Apr; 50(2):144-153. PubMed ID: 37066059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transfusion-Transmitted Bacterial Infections - Haemovigilance Data of German Blood Establishments (1997-2010).
    Funk MB; Lohmann A; Guenay S; Henseler O; Heiden M; Hanschmann KM; Keller-Stanislawski B
    Transfus Med Hemother; 2011; 38(4):266-271. PubMed ID: 22016698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Residual risk and retrospective analysis of transfusion-transmitted bacterial infection reported by the French National Hemovigilance Network from 2000 to 2008.
    Lafeuillade B; Eb F; Ounnoughene N; Petermann R; Daurat G; Huyghe G; Vo Mai MP; Caldani C; Rebibo D; Weinbreck P
    Transfusion; 2015 Mar; 55(3):636-46. PubMed ID: 25257344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implementation of amotosalen plus ultraviolet A-mediated pathogen reduction for all platelet concentrates in France: Impact on the risk of transfusion-transmitted infections.
    Richard P; Pouchol E; Sandid I; Aoustin L; Lefort C; Chartois AG; Baima A; Malard L; Bacquet C; Ferrera-Tourenc V; Gallian P; Laperche S; Bliem C; Morel P; Tiberghien P
    Vox Sang; 2024 Mar; 119(3):212-218. PubMed ID: 38152857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Risk Minimisation Measures for Blood Components - Based on Reporting Rates of Transfusion-Transmitted Reactions (1997-2013).
    Funk MB; Heiden M; Volkers P; Lohmann A; Keller-Stanislawski B
    Transfus Med Hemother; 2015 Jul; 42(4):240-6. PubMed ID: 26557816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet safety strategies in Japan: impact of short shelf life on the incidence of septic reactions.
    Satake M; Kozakai M; Matsumoto M; Matsubayashi K; Taira R; Goto N
    Transfusion; 2020 Apr; 60(4):731-738. PubMed ID: 32119134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of measures aimed to reduce serious adverse transfusion reactions (hemovigilance data from 1997 to 2008)].
    Funk MB; Günay S; Lohmann A; Henseler O; Keller-Stanislawski B
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2010 Apr; 53(4):347-56. PubMed ID: 20213431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transfusion-related adverse reactions: Data from the National Healthcare Safety Network Hemovigilance Module - United States, 2013-2018.
    Kracalik I; Mowla S; Basavaraju SV; Sapiano MRP
    Transfusion; 2021 May; 61(5):1424-1434. PubMed ID: 33880771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Single-donor (apheresis) platelets and pooled whole-blood-derived platelets--significance and assessment of both blood products].
    Hitzler WE
    Clin Lab; 2014; 60(4):S1-39. PubMed ID: 24779310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The German Haemovigilance System--reports of serious adverse transfusion reactions between 1997 and 2007.
    Keller-Stanislawski B; Lohmann A; Günay S; Heiden M; Funk MB
    Transfus Med; 2009 Dec; 19(6):340-9. PubMed ID: 19725904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal analysis of annual national hemovigilance data to assess pathogen reduced platelet transfusion trends during conversion to routine universal clinical use and 7-day storage.
    Pitman JP; Payrat JM; Park MS; Liu K; Corash L; Benjamin RJ
    Transfusion; 2023 Apr; 63(4):711-723. PubMed ID: 36802055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transfusion-Transmitted Infections Reported to the National Healthcare Safety Network Hemovigilance Module.
    Haass KA; Sapiano MRP; Savinkina A; Kuehnert MJ; Basavaraju SV
    Transfus Med Rev; 2019 Apr; 33(2):84-91. PubMed ID: 30930009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nationwide Implementation of Pathogen Inactivation for All Platelet Concentrates in Switzerland.
    Jutzi M; Mansouri Taleghani B; Rueesch M; Amsler L; Buser A
    Transfus Med Hemother; 2018 May; 45(3):151-156. PubMed ID: 29928168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Report on notifications pursuant to Section 21 German Transfusion Act for 2007].
    Henseler O; Heiden M; Haschberger B; Hesse J; Seitz R
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2009 Jul; 52(7):715-31. PubMed ID: 19572110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Transfusion transmitted bacterial infectious (TTBI) with blood component accountability score 2: Retrospective analysis of the French e-fit database 2000-2007. Groupe de travail–validation des IBTT (Working group for validation of transfusion-transmitted bacterial infections)].
    Delbosc A; Lafeuillade B; Petermann R; Eb F; Ounnoughene N
    Transfus Clin Biol; 2011 Feb; 18(1):26-35. PubMed ID: 21310643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A national surveillance system for continuous monitoring of blood transfusion safety: German haemovigilance data.
    Berg P; Heiden M; Müller S; Meyer B; Witzenhausen C; Ruppert-Seipp G; Kehr S; Funk MB
    Vox Sang; 2024 Jun; ():. PubMed ID: 38889998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylactic plasma transfusion for patients without inherited bleeding disorders or anticoagulant use undergoing non-cardiac surgery or invasive procedures.
    Huber J; Stanworth SJ; Doree C; Fortin PM; Trivella M; Brunskill SJ; Hopewell S; Wilkinson KL; Estcourt LJ
    Cochrane Database Syst Rev; 2019 Nov; 11(11):CD012745. PubMed ID: 31778223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogen-reduced platelets for the prevention of bleeding.
    Butler C; Doree C; Estcourt LJ; Trivella M; Hopewell S; Brunskill SJ; Stanworth S; Murphy MF
    Cochrane Database Syst Rev; 2013 Mar; (3):CD009072. PubMed ID: 23543569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Massive Blood Transfusion in Patients with Ruptured Abdominal Aortic Aneurysm.
    Montan C; Hammar U; Wikman A; Berlin E; Malmstedt J; Holst J; Wahlgren CM
    Eur J Vasc Endovasc Surg; 2016 Nov; 52(5):597-603. PubMed ID: 27605360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.